Rep. Cleo Fields (D-LA) Buys Quantinuum (QNT) Stock

Congressional Stock Disclosure Highlights Quantinuum Purchase

Democratic Representative Cleo Fields added to his technology sector holdings by purchasing shares of Quantinuum Inc. (NasdaqGM: QNT). According to a periodic transaction report filed under the STOCK Act on June 26, 2026, the trade took place on June 4, 2026. The disclosed transaction value fell within the range of $1,001 and $15,000. Congressional stock disclosures are filed after transactions occur and offer a look at lawmaker portfolio adjustments.

Quantinuum Stock Price and Market Context

Quantinuum shares change hands around $51.58, sitting inside a 52-week trading boundary of $46.54 to $86.79. The company has a market capitalization near $2.01 billion. Because the firm focuses on quantum computing hardware and software, its financial metrics reflect heavy investment phases typical of early-stage deep technology creators. The enterprise does not carry a positive price-to-earnings ratio as it continues to record a net loss per share.

Recent Earnings and Financial Position

For recent periods, Quantinuum posted revenue of $22.97 million alongside an annual revenue growth rate of 2.79%. The firm reported an earnings per share figure of negative $8.20. Observers can monitor the company's financial progress when its next earnings report arrives on November 9, 2026, which will provide updated figures on revenue expansion and cash management.

Analysts Set New Price Targets

Wall Street firms maintain an active coverage map for Quantinuum with twelve analyst opinions resulting in a consensus strong buy recommendation. On June 29, 2026, Morgan Stanley initiated coverage with an equal-weight rating and a $78 price target, while TD Cowen initiated with a buy rating. Later on August 12, 2026, Needham reiterated its buy rating with a $100 price target and Cantor Fitzgerald reaffirmed its overweight rating at a $90 target. Bernstein kept an outperform rating with a $95 target on August 12, 2026, and Rosenblatt maintained a buy rating with a $155 target on August 19, 2026. Morgan Stanley later updated its view by upgrading the stock to overweight with a $62 target on October 15, 2026. The overall average analyst price target sits at $97.17.

Inside Quantinuum Operations

Headquartered in Broomfield, Colorado, Quantinuum creates and manufactures quantum computing hardware and software platforms for clients in the United States and across international markets. The company develops integrated platforms combining quantum hardware systems and middleware with developer tools and application libraries. Founded in 2021, the enterprise employs about 800 people and operates within the software application industry to make quantum tools usable in real-world environments.

What to Watch Next for Quantinuum

Market participants tracking Quantinuum will look toward future congressional disclosures to see if additional lawmakers adjust their positions in the quantum computing sector. On the corporate side, attention turns to the upcoming earnings release on November 9, 2026, alongside further analyst updates. Periodic transaction reports filed under the STOCK Act remain backward-looking records and do not necessarily reflect current portfolio weightings.